Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04536077
Title Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Washington University School of Medicine
Indications

pancreatic ductal adenocarcinoma

Therapies

CDX-1140 + CDX-301

CDX-1140

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST